• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

周细胞覆盖减少前列腺癌异种移植瘤中肿瘤细胞向血管的侵袭。

Pericyte coverage decreases invasion of tumour cells into blood vessels in prostate cancer xenografts.

作者信息

Welén K, Jennbacken K, Tesan T, Damber J-E

机构信息

Department of Urology, Lundberg Laboratory for Cancer Research, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.

出版信息

Prostate Cancer Prostatic Dis. 2009;12(1):41-6. doi: 10.1038/pcan.2008.33. Epub 2008 Jun 3.

DOI:10.1038/pcan.2008.33
PMID:18521102
Abstract

Androgen-independent prostate cancer is an aggressive disease with high angiogenic and metastatic potential. Increased microvessel density and altered invasion properties have previously been described in LNCaP-19, an androgen-independent subline to LNCaP. To characterize the differences in angiogenesis and invasion, the vessels of these tumour xenografts were investigated with immunohistochemistry, and the influence of tumour cells on endothelial cell migration, proliferation and tube formation was studied in vitro. The blood vessels of LNCaP were found to be stabilized by pericytes more frequently than vessels in LNCaP-19. Further, tumour cell invasion was decreased in pericyte-covered blood vessels in both the tumour types. LNCaP-19 displayed an increased potential to induce endothelial cell migration in vitro. In conclusion, pericyte coverage seems to be important for the invasion of tumour cells into blood vessels. Further, LNCaP-19 has lower pericyte coverage and an increased potential to induce endothelial cell migration, which reflects its high microvessel density.

摘要

雄激素非依赖性前列腺癌是一种具有高血管生成和转移潜能的侵袭性疾病。先前在LNCaP - 19(LNCaP的一种雄激素非依赖性亚系)中已描述了微血管密度增加和侵袭特性改变。为了表征血管生成和侵袭的差异,用免疫组织化学方法研究了这些肿瘤异种移植的血管,并在体外研究了肿瘤细胞对内皮细胞迁移、增殖和管形成的影响。发现LNCaP的血管比LNCaP - 19中的血管更频繁地被周细胞稳定。此外,两种肿瘤类型中,周细胞覆盖的血管中肿瘤细胞侵袭均减少。LNCaP - 19在体外诱导内皮细胞迁移的潜能增加。总之,周细胞覆盖似乎对肿瘤细胞侵入血管很重要。此外,LNCaP - 19的周细胞覆盖较低且诱导内皮细胞迁移的潜能增加,这反映了其高微血管密度。

相似文献

1
Pericyte coverage decreases invasion of tumour cells into blood vessels in prostate cancer xenografts.周细胞覆盖减少前列腺癌异种移植瘤中肿瘤细胞向血管的侵袭。
Prostate Cancer Prostatic Dis. 2009;12(1):41-6. doi: 10.1038/pcan.2008.33. Epub 2008 Jun 3.
2
Stromal cells promote angiogenesis and growth of human prostate tumors in a differential reactive stroma (DRS) xenograft model.在差异反应性基质(DRS)异种移植模型中,基质细胞促进人前列腺肿瘤的血管生成和生长。
Cancer Res. 2002 Jun 1;62(11):3298-307.
3
Promotion of angiogenesis by ps20 in the differential reactive stroma prostate cancer xenograft model.ps20在差异反应性基质前列腺癌异种移植模型中对血管生成的促进作用。
Cancer Res. 2003 Sep 15;63(18):5859-65.
4
Differential expression of angiopoietin-2 and vascular endothelial growth factor in androgen-independent prostate cancer models.血管生成素-2和血管内皮生长因子在雄激素非依赖性前列腺癌模型中的差异表达
BJU Int. 2008 Sep;102(8):1034-9. doi: 10.1111/j.1464-410X.2008.07768.x. Epub 2008 May 16.
5
Transition of an androgen-dependent human prostate cancer cell line into an androgen-independent subline is associated with increased angiogenesis.雄激素依赖性人前列腺癌细胞系向雄激素非依赖性亚系的转变与血管生成增加有关。
Prostate. 2005 Mar 1;62(4):364-73. doi: 10.1002/pros.20145.
6
Targeting of pericytes diminishes neovascularization and lymphangiogenesis in prostate cancer.靶向周细胞可减少前列腺癌中的新生血管形成和淋巴管生成。
Prostate. 2006 Feb 15;66(3):294-304. doi: 10.1002/pros.20346.
7
Ectopical expression of human MUC18 increases metastasis of human prostate cancer cells.人MUC18的异位表达增加人前列腺癌细胞的转移。
Gene. 2004 Mar 3;327(2):201-13. doi: 10.1016/j.gene.2003.11.018.
8
Prostate cancer progression into androgen independency is associated with alterations in cell adhesion and invasivity.前列腺癌进展为雄激素非依赖性与细胞黏附性和侵袭性的改变有关。
Prostate. 2006 Nov 1;66(15):1631-40. doi: 10.1002/pros.20469.
9
Murine androgen-independent neuroendocrine carcinoma promotes metastasis of human prostate cancer cell line LNCaP.小鼠雄激素非依赖性神经内分泌癌促进人前列腺癌细胞系LNCaP的转移。
Prostate. 2006 Apr 1;66(5):536-45. doi: 10.1002/pros.20369.
10
Pericytes and endothelial precursor cells: cellular interactions and contributions to malignancy.周细胞与内皮前体细胞:细胞间相互作用及其对恶性肿瘤的影响
Cancer Res. 2005 Nov 1;65(21):9741-50. doi: 10.1158/0008-5472.CAN-04-4337.

引用本文的文献

1
Pericytes in castration-resistant prostate cancer associated with disease progression and immunotherapy response: insights from single-cell analysis.去势抵抗性前列腺癌中的周细胞与疾病进展和免疫治疗反应相关:单细胞分析的见解
Cancer Cell Int. 2025 Jun 3;25(1):200. doi: 10.1186/s12935-025-03838-3.
2
Combination Treatment of TRPV4 Agonist with Cisplatin Promotes Vessel Normalization in an Animal Model of Oral Squamous Cell Carcinoma.TRPV4 激动剂联合顺铂促进口腔鳞状细胞癌动物模型中的血管正常化。
Medicina (Kaunas). 2022 Sep 6;58(9):1229. doi: 10.3390/medicina58091229.
3
The cell-line-derived subcutaneous tumor model in preclinical cancer research.
临床前癌症研究中的细胞系衍生的皮下肿瘤模型。
Nat Protoc. 2022 Sep;17(9):2108-2128. doi: 10.1038/s41596-022-00709-3. Epub 2022 Jul 20.
4
Seminal Vesicle Tumor Microenvironment.精囊肿瘤微环境。
Adv Exp Med Biol. 2020;1296:309-318. doi: 10.1007/978-3-030-59038-3_19.
5
Matrix Stiffness Induces Pericyte-Fibroblast Transition Through YAP Activation.基质硬度通过YAP激活诱导周细胞-成纤维细胞转变。
Front Pharmacol. 2021 May 31;12:698275. doi: 10.3389/fphar.2021.698275. eCollection 2021.
6
Prostaglandin E2 breaks down pericyte-endothelial cell interaction via EP1 and EP4-dependent downregulation of pericyte N-cadherin, connexin-43, and R-Ras.前列腺素 E2 通过 EP1 和 EP4 依赖性地下调周细胞 N-钙黏蛋白、连接蛋白-43 和 R-Ras,破坏周细胞-内皮细胞相互作用。
Sci Rep. 2020 Jul 7;10(1):11186. doi: 10.1038/s41598-020-68019-w.
7
Carbonic anhydrase 2 (CAII) supports tumor blood endothelial cell survival under lactic acidosis in the tumor microenvironment.碳酸酐酶 2(CAII)在肿瘤微环境的酸中毒条件下支持肿瘤血管内皮细胞的存活。
Cell Commun Signal. 2019 Dec 17;17(1):169. doi: 10.1186/s12964-019-0478-4.
8
Tumor Microenvironment Targeted Nanotherapy.肿瘤微环境靶向纳米疗法
Front Pharmacol. 2018 Oct 31;9:1230. doi: 10.3389/fphar.2018.01230. eCollection 2018.
9
Immunotherapeutic Targeting of Tumor-Associated Blood Vessels.免疫治疗肿瘤相关血管。
Adv Exp Med Biol. 2017;1036:191-211. doi: 10.1007/978-3-319-67577-0_13.
10
Antiangiogenic effects of recombinant human endostatin in lung cancers.重组人血管内皮抑制素对肺癌的抗血管生成作用。
Mol Med Rep. 2018 Jan;17(1):79-86. doi: 10.3892/mmr.2017.7859. Epub 2017 Oct 24.